This is the first phase 3 trial to show histologic resolution of MASH (formerly NASH) with semaglutide, highlighting its therapeutic potential for liver disease independent of diabetes
Managing Multiple Vials and Rotation Schedules Patients receiving multiple months of tirzepatide at once should rotate stock by using older vials firstthe 'first in, first out' principleto minimize expiration waste
Wegovy is an excellent choice for those seeking a targeted, effective, and manageable solution for weight loss, especially if other treatments have not been effective
Background For our study, we leveraged a de-identified dataset representing the general U.S
Today, GLP-1 drugs account for about 15% of monthly revenue in practices that offer them, and approximately 40% of patients receiving GLP-1 treatments in 2024 were new to those practices
It's crucial to discuss any potential interactions with your healthcare provider before starting carnitine supplementation